Metals Focus expects platinum group metals markets to remain in deficit through 2026, with tightening supply and stronger demand supporting higher prices.
Effective treatments for Alzheimer's, MND and other neurodegenerative diseases remain elusive, but a handful of ASX biotechs are working to shift the odds.